Regeneron, Sanofi Didn't Warn About Cancer Risk, Suit Says
Regeneron Pharmaceuticals and Sanofi-Aventis were sued Tuesday in Georgia federal court by a woman who said she experienced rapid progression of cutaneous T-cell lymphoma after getting injections of dupilumab, a medication...To view the full article, register now.
Already a subscriber? Click here to view full article